1-4 of 4
Elke Pogge von Strandmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT341: AFM13: an antigen specific immunotherapy for the treatment of CD30+ malignancies: Results of first-in-man study in relapsed/refractory (R/R) Hodgkin lymphoma (HL)

Free
Achim Rothe, Katrin S. Reiners, Max S. Topp, Anas Younes, Bastian von Tresckow, Horst Dieter Hummel, Joerg Kessler, Miroslav Ravic, Jens-Peter Marschner, Elke Pogge von Strandmann, Andreas Engert
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT341.
https://doi.org/10.1158/1538-7445.AM2014-CT341
Published: 01 October 2014
View articletitled, Abstract CT341: AFM13: an antigen specific immunotherapy for the treatment of CD30+ malignancies: Results of first-in-man study in relapsed/refractory (R/R) Hodgkin lymphoma (HL)
Journal Articles

Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell–Activating Receptor NKp30

Free
Eva Schlecker, Nathalie Fiegler, Annette Arnold, Peter Altevogt, Stefan Rose-John, Gerhard Moldenhauer, Antje Sucker, Annette Paschen, Elke Pogge von Strandmann, Sonja Textor, Adelheid Cerwenka
Journal: Cancer Research
Cancer Res (2014) 74 (13): 3429–3440.
https://doi.org/10.1158/0008-5472.CAN-13-3017
Published: 30 June 2014
View articletitled, Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell–Activating Receptor NKp30
Open the PDF for Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell–Activating Receptor NKp30 in another window
Includes: Supplementary data
Journal Articles

Abstract 4572: The CD30/CD16A RECRUIT TandAb AFM13 activates patient NK cells resulting in specific tumor cell killing.

Free
Achim Rothe, Max S. Topp, Anas Younes, Uwe Reusch, Stefan Knackmuss, Erich Rajkovic, Dennis A. Eichenauer, Horst Hummel, Katrin S. Reiners, Markus Dietlein, Joerg Kessler, Miroslav Ravic, Christian Hucke, Eugene Zhukovsky, Elke Pogge von Strandmann, Andreas Engert
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4572.
https://doi.org/10.1158/1538-7445.AM2013-4572
Published: 15 April 2013
View articletitled, Abstract 4572: The CD30/CD16A RECRUIT TandAb AFM13 activates patient NK cells resulting in specific tumor cell killing.
Journal Articles

ADAM10 Inhibition of Human CD30 Shedding Increases Specificity of Targeted Immunotherapy In vitro

Free
Dennis A. Eichenauer, Vijaya Lakshmi Simhadri, Elke Pogge von Strandmann, Andreas Ludwig, Vance Matthews, Katrin S. Reiners, Bastian von Tresckow, Paul Saftig, Stefan Rose-John, Andreas Engert, Hinrich P. Hansen
Journal: Cancer Research
Cancer Res (2007) 67 (1): 332–338.
https://doi.org/10.1158/0008-5472.CAN-06-2470
Published: 08 January 2007
View articletitled, ADAM10 Inhibition of Human CD30 Shedding Increases Specificity of Targeted Immunotherapy In vitro
Open the PDF for ADAM10 Inhibition of Human CD30 Shedding Increases Specificity of Targeted Immunotherapy In vitro in another window